Stay updated on Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial
Sign up to get notified when there's something new on the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page.

Latest updates to the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page UI revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change rather than a change to the underlying trial study details.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page shows Revision: v3.5.0, replacing the previous v3.4.3. This appears to be a minor version update with no impact on study details or navigation.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 in the revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedAdded a new publication citation (Andreatta et al., J Antimicrob Chemother, 2019) with revision 3.4.1, and removed the Erratum reference for the same article (revision 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to B/F/TAF in Virologically Suppressed Adults Clinical Trial page.